| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/13/2005 | CN1636546A Sprayable skin protectant compositions |
| 07/13/2005 | CN1636545A A composition for external use |
| 07/13/2005 | CN1636544A A composition for external use |
| 07/13/2005 | CN1210279C Thiazolo (4,5-D) pyrimidine compounds |
| 07/13/2005 | CN1210273C Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/13/2005 | CN1210270C Novel use of phenylheteroalkylamine derivatives |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/13/2005 | CN1210066C Cloning pigs using donor nuclei from differentiated cells |
| 07/13/2005 | CN1210042C Polymer and methods of formulating same |
| 07/13/2005 | CN1210041C Complex external medicine for treating acne |
| 07/13/2005 | CN1210040C Prepn process of combined delayed releasing agent for preventing and treating animal's tinea pedis and mite disease |
| 07/13/2005 | CN1210035C Complex external medicine for treating psoriasis |
| 07/13/2005 | CN1210034C Medicinal composition for treating psoriasis |
| 07/13/2005 | CN1210029C Pharmaceutical use for piperine and method for cosmetically promoting the natural coloration of the skin |
| 07/13/2005 | CN1210014C Anti-perspirant deodorizing composition and preparation process thereof |
| 07/13/2005 | CN1210010C Shampoo with functions of calvities-proof and hair-growth |
| 07/12/2005 | US6917616 Method and apparatus for reduction and restoration of data elements pertaining to transmitted data packets in a communications network |
| 07/12/2005 | US6916848 Compounds for the treatment of metabolic disorders |
| 07/12/2005 | US6916844 Hydroxy pyranone derivative and preparation method thereof |
| 07/12/2005 | US6916838 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/12/2005 | US6916834 Preparations and use of an Ah receptor ligand, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/12/2005 | US6916810 αν integrin receptor antagonists |
| 07/12/2005 | US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme |
| 07/12/2005 | US6916807 Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 07/12/2005 | US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 07/12/2005 | US6916798 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease |
| 07/12/2005 | US6916485 Mixture of protein, hydrophilic polymer, group 1a alkyl sulfate and sugar |
| 07/12/2005 | US6916479 Compositions containing an antifungal and a phospholipid |
| 07/12/2005 | CA2341739C Quinolin-2-one derivatives useful as anticancer agents |
| 07/12/2005 | CA2323008C Pharmaceutically active compounds |
| 07/12/2005 | CA2277168C Personal cleansing compositions |
| 07/12/2005 | CA2263037C Oxidation dyeing technique and oxidation dyeing composition for keratin fibres, employing a cationic amphiphilic polymer |
| 07/07/2005 | US20050148670 Skin disorders; antiinflammatory agents; antiproliferative agents; controlling metabolism; obesity; antilipemic agents; antihistamines |
| 07/07/2005 | US20050148664 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine |
| 07/07/2005 | US20050148636 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 07/07/2005 | US20050148625 Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions |
| 07/07/2005 | US20050148624 Enzyme inhibitors with isoquinolinone structures |
| 07/07/2005 | US20050148619 Sulfonamido ether substituted imidazoquinolines |
| 07/07/2005 | US20050148608 Chymase enzyme inhibitors for drugs in vascular systems using sulfonylurea derivatives |
| 07/07/2005 | US20050148607 Administering to show overactivation or expression from diagnosis of diseases, immunoassay, anticancer agents or skin disorders |
| 07/07/2005 | US20050148604 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 07/07/2005 | US20050148599 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 07/07/2005 | US20050148591 Tartrate salts of 5,8,14-triazatetracyclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen and pharmaceutical compositions thereof |
| 07/07/2005 | US20050148588 LFA-1 antagonist compounds |
| 07/07/2005 | US20050148578 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 07/07/2005 | US20050148577 2-methyl-1,8-dioxa-dibenzo[e,h]azulene; potentiation; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 07/07/2005 | US20050148576 Dibenzo[b.f]oxazolo-azulines, -oxepines and -thiepines; antiinflammatories; analgesics |
| 07/07/2005 | US20050148550 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 07/07/2005 | US20050148537 Immunostimulatory nucleic acid molecules |
| 07/07/2005 | US20050148527 Catalytic nucleic acids; ribozymes; translation inhibition; gene expression inhibition; for treating cardiovascular disease; for neovascularization induction in heart tissue |
| 07/07/2005 | US20050148498 Metalloprotease inhibiting activity, in particular collagenase and gelatinase, treating humans or mammals suffering from a condition or disease related to excessive degeneration of support by a metalloprotease; treat inflammatory diseases: arthrosis, parodontosis or ulcers |
| 07/07/2005 | US20050148495 Using XMP.629 ( a peptide containing NH2-lys-leu-phe-arg-(1-naphthyl)-ala)-gln-ala-lys(3-naphthyl)-ala)CONH2 or a pharmaceutically acceptable salt or derivative as antiacne agent |
| 07/07/2005 | US20050148034 Using reduced microvessel outgrowth of pluripotent stem cells as diagnostic indicator angoigenseis inhibition; antitumor agents |
| 07/07/2005 | US20050148017 Antisense oligonucleotides against tenascin for the treating of vitiligo |
| 07/07/2005 | US20050147665 Consisting of eicosapentaenoic acid or derivative, vitamin B 12, folic acid, at a maximum daily dose of 5 mg, and vitamin B6, at a maximum daily dose of 20 mg, and optionally at least one antioxidant; treatment of psychiatric disorders; schizophrenia, Alzheimer's disease, dementia, Parkinson's disease |
| 07/07/2005 | US20050147652 Cell delivery system |
| 07/07/2005 | US20050147612 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 07/07/2005 | US20050147578 Skin, hair and/or nails aesthetic appearance; extract of azadiracta seeds with gynostemma, coconut water and/or rhodeola; antiaging, hydrating, texturizing |
| 07/07/2005 | US20050147577 Composition for pharmaceutical or dietetic use for combating hair loss |
| 07/07/2005 | DE10357451A1 Wirkstoffkombinationen aus 2,3-Dibenzylbutyrolactonen und Licochalcon A oder einem wässrigen Extrakt aus Radix Glycyrrhizae inflatae, enthaltend Licochalcon A Active compound combinations of 2,3-Dibenzylbutyrolactonen and licochalcone A or an aqueous extract of Radix Glycyrrhizae inflatae containing licochalcone A |
| 07/07/2005 | DE10105038B4 Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 07/07/2005 | CA2550843A1 Novel phenylalanine derivatives |
| 07/07/2005 | CA2546943A1 Novel compounds |
| 07/07/2005 | CA2545085A1 Use of piketprofen for the preparation of a pharmaceutical composition to treat rosacea |
| 07/07/2005 | CA2545080A1 Use of idrocilamide for the preparation of a pharmaceutical composition of rosacea |
| 07/07/2005 | CA2545074A1 Use of fepradinol for the production of a pharmaceutical composition for the treatment of rosacea |
| 07/06/2005 | EP1550667A1 Tyrosinase activity controlling agents, process for producing the same and external preparations containing the same |
| 07/06/2005 | EP1550662A1 Novel adenine compound and use thereof |
| 07/06/2005 | EP1550461A1 Remedy for chronic disease |
| 07/06/2005 | EP1550459A1 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 07/06/2005 | EP1550448A1 Histamine release inhibitor |
| 07/06/2005 | EP1550433A1 Use of ecdysteroids for teh preparation of cosmetic or dermatologic compositions for avoiding the hair loss |
| 07/06/2005 | EP1550429A1 External preparations for skin |
| 07/06/2005 | EP1549756A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 07/06/2005 | EP1549741A1 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances |
| 07/06/2005 | EP1549660A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/06/2005 | EP1549651A1 Kinase inhibitors |
| 07/06/2005 | EP1549640A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/06/2005 | EP1549634A1 Novel substituted indoles |
| 07/06/2005 | EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 07/06/2005 | EP1549398A1 Inhibitors of the fatty acid oxidation for the prophylaxis and/or the treatment of chronic and/or atopic skin diseases |
| 07/06/2005 | EP1549269A2 Cyclodextrin-based materials, compositions and uses related thereto |
| 07/06/2005 | EP1549141A2 Methods and compositions for the treatment of autoimmune disorders using clofarabine |
| 07/06/2005 | EP1411938B1 Use of cyclopamine for the manufacture of a medicament for the treatemnt of psoriasis |
| 07/06/2005 | EP1373256B1 Ccr5 antagonists useful for treating aids |
| 07/06/2005 | EP1171089B1 Skin care compositions containing combination of skin care actives |
| 07/06/2005 | EP1045902B1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME |
| 07/06/2005 | EP1044001B1 Integrin receptor antagonists |
| 07/06/2005 | EP0904042B1 Cosmetic composition for rejuvenation of skin without skin irritation |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 07/06/2005 | CN1636064A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 07/06/2005 | CN1636061A Novel serine protease genes related to DPPIV |
| 07/06/2005 | CN1636059A Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2 |
| 07/06/2005 | CN1636007A Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 07/06/2005 | CN1636005A Benzothiazinone and benzoxazinone compounds |
| 07/06/2005 | CN1636003A Vitamin D3 derivatives and remedies using the same |
| 07/06/2005 | CN1635979A IL-8 receptor antagonists |
| 07/06/2005 | CN1635910A Treatment and diagnosis of macrophage mediated disease |
| 07/06/2005 | CN1635908A Antibodies that immunospecifically bind to trail receptors |
| 07/06/2005 | CN1635907A Topical compositions and methods for treatment of adverse effects of ionizing radiation |